NorthX Biologics appoints Patrick DePalma Senior Vice President of North American Business Development
Biopharmaceutical contract development and manufacturing organization (CDMO) NorthX Biologics is pleased to announce the appointment of Patrik DePalma as Senior Vice President of Business Development in North America. With over ...
Amarna Therapeutics partners with NorthX Biologics to advance Nimvec™ AM510 gene therapy development
Amarna Therapeutics, a privately held biotechnology company specializing in transformative gene therapies, is pleased to announce its strategic collaboration with NorthX Biologics, a leading biologics manufacturing partner. This partnership represents ...
Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy
Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has entered a strategic collaboration with NorthX Biologics, a leading CDMO, to advance manufacturing strategies for Neogap’s personalised cancer cell therapy. Supported by ...
NorthX Biologics Innovation Hub supports Abera Bioscience with nasal pneumococcal vaccine
Abera Bioscience AB has been awarded a 1 million SEK grant from Vinnova to advance the development of its innovative pneumococcal vaccine, Ab-01.12, towards clinical trials. The vaccine, which is ...
NorthX Biologics strengthens leadership team with Magnus Gustafsson as Chief Commercial Officer
Biopharmaceutical contract development and manufacturing organization (CDMO) NorthX Biologics, is pleased to announce the appointment of Magnus Gustafsson as Chief Commercial Officer (CCO). Magnus brings an exceptional wealth of experience ...
Lipum and NorthX Biologics enter into new strategic manufacturing alliance
Lipum AB (Publ), a clinical stage biopharmaceutical company specialized in discovery and development of a novel treatment for chronic inflammatory diseases today announces thatit has entered into a manufacturing alliance ...
Synerkine Pharma and NorthX Biologics sign manufacturing alliance
Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, today announced a manufacturing alliance with NorthX Biologics AB, a leading biopharmaceutical company committed to pioneering solutions in gene therapy ...
NorthX Biologics AB introduces proprietary AAV plasmids, bolstering comprehensive gene therapy support
NorthX Biologics AB, a pioneer in biopharmaceutical innovation, is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV (Adeno-Associated Virus) vectors for gene therapy. ...
More than a hundred advanced biologics frontrunners gathered at our first-class manufacturing site in Matfors
The future of advanced biologics On 26-28 September NorthX successfully arranged the conference ”the future of advanced biologics” where over 100 front-runners from the life science field were invited to ...